It has been well-documented that patient populations managing chronic illnesses or co-morbidities, such as sleep apnea and obesity, are particularly vulnerable to respiratory depression. Current practices for monitoring patients receiving opioids are still not adequate or comprehensive. For example, reliance on periodic physical spot checks by direct-care clinical staff can leave patients largely unmonitored up to 96% of the time.<\/p>\n
An award-winning not-for-profit community hospital chose Bernoulli One<\/em>\u2122 to enable real-time surveillance of post-operative patients who were at risk for respiratory depression. Following the success of that initial implementation, the hospital has subsequently expanded usage to all at-risk patients being monitored by pulse oximetry and capnography, while leveraging the Bernoulli platform for alarm management, reducing the estimated number of alarms by 78%.<\/p>\n According to the health system\u2019s director of respiratory care services, \u201cBernoulli became just a part of our day-to-day operations. We\u2019re able to safely monitor patients across the entire facility without the constant distraction and fatigue of responding to false alarms. Our nurses and respiratory therapists know it\u2019s there and know it\u2019s working.\u201d<\/p>\n